Metabolomic profiling of pheochromocytomas in dogs: Catecholamine phenotype and tricarboxylic acid cycle metabolites
Journal of Veterinary Internal Medicine · 2024
DOI: 10.1111/jvim.17148 ↗At a glance
Journal article in Journal of Veterinary Internal Medicine, 2024. Written by Marit F van den Berg and 6 co-authors. Institution: Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands. Major MEDLINE topics: Pheochromocytoma, Citric Acid Cycle, Adrenal Gland Neoplasms, Dog Diseases. Cited 6 times so far (Crossref); 36 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Maria Naundorf van Gorkum Foundation, Foundation Abri, Friends of VetMed.
Abstract (original language)
Background
In humans with pheochromocytomas (PCCs), targeted metabolomics is used to determine the catecholamine phenotype or to uncover underlying pathogenic variants in tricarboxylic acid (TCA) cycle genes such as succinate dehydrogenase subunits (SDHx). Hypothesis/Objectives To analyze catecholamine contents and TCA cycle metabolites of PCCs and normal adrenals (NAs). Animals Ten healthy dogs, 21 dogs with PCC.
Methods
Prospective observational study. Dogs diagnosed with PCC based on histopathological and immunohistochemical confirmation were included. Tissue catecholamine contents and TCA metabolites in PCCs and NAs were measured by liquid chromatography with mass spectrometry or electrochemical detection.
Results
Compared to NAs, PCCs had significantly higher tissue proportion of norepinephrine (88% [median: range, 38%-98%] vs 14% [11%-26%]; P < .001), and significantly lower tissue proportion of epinephrine (12% [1%-62%] vs 86% [74%-89%]; P < .001). Pheochromocytomas exhibited significantly lower fumarate (0.4-fold; P < .001), and malate (0.5-fold; P = .008) contents than NAs. Citrate was significantly higher in PCCs than in NAs (1.6-fold; P = .015). One dog in the PCC group had an aberrant succinate : fumarate ratio that was 25-fold higher than in the other PCCs, suggesting an SDHx mutation. Conclusions and Clinical Importance This study reveals a distinct catecholamine content and TCA cycle metabolite profile in PCCs. Metabolite profiling might be used to uncover underlying pathogenic variants in TCA cycle genes in dogs.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
- Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
ORCID profiles: Marit F van den Berg, Sara Galac
Funding
- Maria Naundorf van Gorkum Foundation
- Foundation Abri
- Friends of VetMed
Cite
APA
van den Berg, M. F., Bechmann, N., Kooistra, H. S., van Wolferen, M. E., Timmermans-Sprang, E. P. M., Peitzsch, M., & Galac, S. (2024). Metabolomic profiling of pheochromocytomas in dogs: Catecholamine phenotype and tricarboxylic acid cycle metabolites. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17148
Vancouver
van den Berg MF, Bechmann N, Kooistra HS, van Wolferen ME, Timmermans-Sprang EPM, Peitzsch M, et al. Metabolomic profiling of pheochromocytomas in dogs: Catecholamine phenotype and tricarboxylic acid cycle metabolites. Journal of Veterinary Internal Medicine. 2024. doi:10.1111/jvim.17148
BibTeX
@article{vandenBerg2024,
author = {van den Berg, Marit F and Bechmann, Nicole and Kooistra, Hans S and van Wolferen, Monique E and Timmermans-Sprang, Elpetra P M and Peitzsch, Mirko and Galac, Sara},
title = {Metabolomic profiling of pheochromocytomas in dogs: Catecholamine phenotype and tricarboxylic acid cycle metabolites},
journal = {Journal of Veterinary Internal Medicine},
year = {2024},
doi = {10.1111/jvim.17148}
}
EUVIMED